Anti-apoptotic therapeutic approaches in liver diseases: Do they really make sense?

Apoptosis

Volumn 19, Issue 8, 2014, Pages 1243-1253

  Bannert, Karen ^a   Kuhla, Angela ^a   Abshagen, Kerstin ^a   Vollmar, Brigitte ^a  

^a UNIVERSITY OF ROSTOCK   (Germany)

Author keywords

Caspase 3; Cholestasis; Experimental; Ischemia reperfusion; Liver cirrhosis; Sepsis

Indexed keywords

CASPASE 3; NICOTINAMIDE ADENINE DINUCLEOTIDE ADENOSINE DIPHOSPHATE RIBOSYLTRANSFERASE 1; NICOTINAMIDE ADENINE DINUCLEOTIDE ADENOSINE DIPHOSPHATE RIBOSYLTRANSFERASE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; APOPTOSIS; ARTICLE; CELL DEATH; CONTROLLED STUDY; ENZYME ACTIVATION; LIVER CELL; LIVER DISEASE; LIVER INJURY; MOUSE; NICK END LABELING; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; ANIMAL; CHOLESTASIS; COMPLICATION; DRUG EFFECTS; LIVER; LIVER CIRRHOSIS; LIVER DISEASES; LIVER REGENERATION; METABOLISM; PATHOLOGY; REPERFUSION INJURY; SEPSIS; VASCULARIZATION;

ANIMALS; APOPTOSIS; CASPASE 3; CHOLESTASIS; LIVER; LIVER CIRRHOSIS; LIVER DISEASES; LIVER REGENERATION; MICE; POLY(ADP-RIBOSE) POLYMERASES; REPERFUSION INJURY; SEPSIS;

EID: 84904244547     PISSN: 13608185     EISSN: 1573675X     Source Type: Journal    
DOI: 10.1007/s10495-014-1004-1     Document Type: Article

References (65)

1. Schuchmann M, Galle PR (2001) Apoptosis in liver disease. Eur J Gastroenterol Hepatol 13:785-790 (Pubitemid 32656591)
2. Yoon JH, Gores GJ (2002) Death receptor-mediated apoptosis and the liver. J Hepatol 37:400-410
3. Gujral JS, Knight TR, Farhood A, Bajt ML, Jaeschke H (2002) Mode of cell death after acetaminophen overdose in mice: apoptosis or oncotic necrosis? Toxicol Sci 67:322-328 (Pubitemid 34746486)
4. Maier S, Traeger T, Entleutner M, Westerholt A, Kleist B, Huser N, Holzmann B, Stier A, Pfeffer K, Heidecke CD (2004) Cecal ligation and puncture versus colon ascendens stent peritonitis: two distinct animal models for polymicrobial sepsis. Shock 21:505-511
5. Georgiev P, Jochum W, Heinrich S, Jang JH, Nocito A, Dahm F, Clavien PA (2008) Characterization of time-related changes after experimental bile duct ligation. Br J Surg 95:646-656
6. Tarcin O, Basaranoglu M, Tahan V, Tahan G, Sucullu I, Yilmaz N, Sood G, Snyder N, Hilman G, Celikel C, Tozun N (2011) Time course of collagen peak in bile duct-ligated rats. BMC Gastroenterol 11:45
7. Constandinou C, Henderson N, Iredale JP (2005) Modeling liver fibrosis in rodents. Methods Mol Med 117:237-250
8. Fausto N (2000) Liver regeneration. J Hepatol 32:19-31
9. Eipel C, Hirschmann M, Abshagen K, Menger MD, Vollmar B (2007) Local interaction of apoptotic hepatocytes and Kupffer cells in a rat model of systemic endotoxemia. Hepatol Res 37:863-871 (Pubitemid 47308229)
10. El-Gibaly AM, Scheuer C, Menger MD, Vollmar B (2004) Improvement of rat liver graft quality by pifithrin-alpha-mediated inhibition of hepatocyte necrapoptosis. Hepatology 39:1553-1562 (Pubitemid 38702656)
11. Kaufmann SH, Desnoyers S, Ottaviano Y, Davidson NE, Poirier GG (1993) Specific proteolytic cleavage of poly(ADP-ribose) polymerase: an early marker of chemotherapy-induced apoptosis. Cancer Res 53:3976-3985 (Pubitemid 23267698)
12. Brauns SC, Dealtry G, Milne P, Naudé R, Van de Venter M (2005) Caspase-3 activation and induction of PARP cleavage by cyclic dipeptide cyclo(Phe-Pro) in HT-29 cells. Anticancer Res 25:4197-4202 (Pubitemid 41665204)
13. Chaitanya GV, Steven AJ, Babu PP (2010) PARP-1 cleavage fragments: signatures of cell-death proteases in neurodegeneration. Cell Commun Signal 8:31
14. Schmidt ES, Schmidt FW (1988) Glutamate dehydrogenase: biochemical and clinical aspects of an interesting enzyme. Clin Chim Acta 173:43-55
15. Eichhorst ST (2005) Modulation of apoptosis as a target for liver disease. Expert Opin Ther Targets 9:83-99
16. Gujral JS, Bucci TJ, Farhood A, Jaeschke H (2001) Mechanism of cell death during warm hepatic ischemia-reperfusion in rats: apoptosis or necrosis? Hepatology 33:397-405 (Pubitemid 32119028)
17. Redaelli CA, Tian YH, Schaffner T, Ledermann M, Baer HU, Dufour JF (2002) Extended preservation of rat liver graft by induction of heme oxygenase-1. Hepatology 35:1082-1092 (Pubitemid 34454005)
18. Jaeschke H, Lemasters JJ (2003) Apoptosis versus oncotic necrosis in hepatic ischemia/reperfusion injury. Gastroenterology 125:1246-1257 (Pubitemid 37193469)
19. Gujral JS, Liu J, Farhood A, Jaeschke H (2004) Reduced oncotic necrosis in fas receptor-deficient c57bl/6j-lpr mice after bile duct ligation. Hepatology 40:998-1007 (Pubitemid 39288134)
20. Huet PM, Nagaoka MR, Desbiens G, Tarrab E, Brault A, Bralet MP, Bilodeau M (2004) Sinusoidal endothelial cell and hepatocyte death following cold ischemia-warm reperfusion of the rat liver. Hepatology 39:1110-1119 (Pubitemid 38428950)
21. Fickert P, Trauner M, Fuchsbichler A, Zollner G, Wagner M, Marschall HU, Zatloukal K, Denk H (2005) Oncosis represents the main type of cell death in mouse models of cholestasis. J Hepatol 42:378-385 (Pubitemid 40254253)
22. Malhi H, Gores GJ, Lemasters JJ (2006) Apoptosis and necrosis in the liver: a tale of two deaths? Hepatology 43:S31-S44
23. Sigal M, Siebert N, Zechner D, Menschikow E, Abshagen K, Vollmar B, Eipel C (2010) Darbepoetin-alpha inhibits the perpetuation of necro-inflammation and delays the progression of cholestatic fibrosis in mice. Lab Invest 90:1447-1456
24. Woolbright BL, Jaeschke H (2012) Novel insight into mechanisms of cholestatic liver injury. World J Gastroenterol 18:4985-4993
25. Schulze-Bergkamen H, Schuchmann M, Fleischer B, Galle PR (2006) The role of apoptosis versus oncotic necrosis in liver injury: facts or faith? J Hepatol 44:984-993
26. Soldani C, Scovassi AI (2002) Poly(ADP-ribose) polymerase-1 cleavage during apoptosis: an update. Apoptosis 4:321-328 (Pubitemid 34832256)
27. Watanabe M, Hitomi M, van der Wee K, Rothenberg F, Fisher SA, Zucker R, Svoboda KK, Goldsmith EC, Heiskanen KM, Nieminen AL (2002) The pros and cons of apoptosis assays for use in the study of cells, tissues, and organs. Microsc Microanal 8:375-391 (Pubitemid 35456712)
28. Montalvo-Jave EE, Escalante-Tattersfield T, Ortega-Salgado JA, Pina E, Geller DA (2008) Factors in the pathophysiology of the liver ischemia-reperfusion injury. J Surg Res 147:153-159 (Pubitemid 351626076)
29. Abu-Amara M, Yang SY, Tapuria N, Fuller B, Davidson B, Seifalian A (2010) Liver ischemia/reperfusion injury: processes in inflammatory networks - a review. Liver Transpl 16:1016-1032
30. Bahde R, Spiegel HU (2010) Hepatic ischaemia-reperfusion injury from bench to bedside. Br J Surg 97:1461-1475
31. Weigand K, Brost S, Steinebrunner N, Buchler M, Schemmer P, Muller M (2012) Ischemia/reperfusion injury in liver surgery and transplantation: pathophysiology. HPB Surg Article ID176723
32. Ikeda T, Yanaga K, Kishikawa K, Kakizoe S, Shimada M, Sugimachi K (1992) Ischemic injury in liver transplantation: difference in injury sites between warm and cold ischemia in rats. Hepatology 16:454-461
33. Gao W, Bentley RC, Madden JF, Clavien PA (1998) Apoptosis of sinusoidal endothelial cells is a critical mechanism of preservation injury in rat liver transplantation. Hepatology 27:1652-1660 (Pubitemid 28264691)
34. Rudiger HA, Graf R, Clavien PA (2003) Liver ischemia: apoptosis as a central mechanism of injury. J Invest Surg 16:149-159 (Pubitemid 36926519)
35. Festi D, Montagnani M, Azzaroli F, Lodato F, Mazzella G, Roda A, Di Biase AR, Roda E, Simoni P, Colecchia A (2007) Clinical efficacy and effectiveness of ursodeoxycholic acid in cholestatic liver diseases. Curr Clin Pharmacol 2:155-177 (Pubitemid 46813424)
36. Jonker JW, Stedman CA, Liddle C, Downes M (2009) Hepatobiliary abc transporters: physiology, regulation and implications for disease. Front Biosci 14:4904-4920
37. Copaci I, Micu L, Iliescu L, Voiculescu M (2005) New therapeutical indications of ursodeoxycholic acid. Rom J Gastroenterol 14:259-266 (Pubitemid 41494480)
38. Roma MG, Toledo FD, Boaglio AC, Basiglio CL, Crocenzi FA, Sanchez Pozzi EJ (2011) Ursodeoxycholic acid in cholestasis: Linking action mechanisms to therapeutic applications. Clin Sci (Lond) 121:523-544
39. Amaral JD, Viana RJ, Ramalho RM, Steer CJ, Rodrigues CM (2009) Bile acids: regulation of apoptosis by ursodeoxycholic acid. J Lipid Res 50:1721-1734
40. Perez MJ, Briz O (2009) Bile-acid-induced cell injury and protection. World J Gastroenterol 15:1677-1689
41. Roma MG, Crocenzi FA, Sanchez Pozzi EA (2008) Hepatocellular transport in acquired cholestasis: new insights into functional, regulatory and therapeutic aspects. Clin Sci (Lond) 114:567-588 (Pubitemid 351589057)
42. Paumgartner G (2010) Pharmacotherapy of cholestatic liver diseases. J Dig Dis 11:119-125
43. Qiao L, Yacoub A, Studer E, Gupta S, Pei XY, Grant S, Hylemon PB, Dent P (2002) Inhibition of the mapk and PI3K pathways enhances udca-induced apoptosis in primary rodent hepatocytes. Hepatology 35:779-789 (Pubitemid 34258371)
44. Schoemaker MH, Conde de la Rosa L, Buist-Homan M, Vrenken TE, Havinga R, Poelstra K, Haisma HJ, Jansen PL, Moshage H (2004) Tauroursodeoxycholic acid protects rat hepatocytes from bile acid-induced apoptosis via activation of survival pathways. Hepatology 39:1563-1573 (Pubitemid 38702657)
45. Rodrigues CM, Ma X, Linehan-Stieers C, Fan G, Kren BT, Steer CJ (1999) Ursodeoxycholic acid prevents cytochrome c release in apoptosis by inhibiting mitochondrial membrane depolarization and channel formation. Cell Death Differ 6:842-854 (Pubitemid 29488082)
46. Zhang Y, Hong JY, Rockwell CE, Copple BL, Jaeschke H, Klaassen CD (2011) Effect of bile duct ligation on bile acid composition in mouse serum and liver. Liver Int 32:58-69
47. Fickert P, Wagner M, Marschall HU, Fuchsbichler A, Zollner G, Tsybrovskyy O, Zatloukal K, Liu J, Waalkes MP, Cover C, Denk H, Hofmann AF, Jaeschke H, Trauner M (2006) 24-Norursodeoxycholic acid is superior to ursodeoxycholic acid in the treatment of sclerosing cholangitis in mdr2 (abcb4) knockout mice. Gastroenterology 130:465-481 (Pubitemid 43202044)
48. Ikeda T, Sato C, Noguchi O, Kobayashi F, Tozuka S, Sakamoto S, Marumo F (1996) Improvement of peripheral blood lymphocyte subsets in primary biliary cirrhosis after ursodeoxycholic acid therapy. J Gastroenterol Hepatol 11:366-372 (Pubitemid 26141853)
49. Issa R, Williams E, Trim N, Kendall T, Arthur MJ, Reichen J, Benyon RC, Iredale JP (2001) Apoptosis of hepatic stellate cells: involvement in resolution of biliary fibrosis and regulation by soluble growth factors. Gut 48:548-557 (Pubitemid 32234801)
50. Koniaris LG, McKillop IH, Schwartz SI, Zimmers TA (2003) Liver regeneration. J Am Coll Surg 197:634-659 (Pubitemid 38223851)
51. Gertsch P, Stipa F, Ho J, Yuen ST, Luk I, Lauder IJ (1997) Changes in hepatic portal resistance and in liver morphology during regeneration: in vitro study in rats. Eur J Surg 163:297-304 (Pubitemid 27215757)
52. Panis Y, McMullan DM, Emond JC (1997) Progressive necrosis after hepatectomy and the pathophysiology of liver failure after massive resection. Surgery 121:142-149 (Pubitemid 27091768)
53. Abshagen K, Eipel C, Menger MD, Vollmar B (2006) Comprehensive analysis of the regenerating mouse liver: an in vivo fluorescence microscopic and immunohistological study. J Surg Res 134:354-362 (Pubitemid 44092805)
54. Sakamoto T, Liu Z, Murase N, Ezure T, Yokomuro S, Poli V, Demetris AJ (1999) Mitosis and apoptosis in the liver of interleukin-6-deficient mice after partial hepatectomy. Hepatology 29:403-411 (Pubitemid 29088443)
55. Taira K, Hiroyasu S, Shiraishi M, Muto Y, Koji T (2001) Role of the Fas system in liver regeneration after a partial hepatectomy in rats. Eur Surg Res 33:334-341 (Pubitemid 34114147)
56. Gupta S (2000) Hepatic polyploidy and liver growth control. Semin Cancer Biol 10:161-171
57. Zimmermann A (2004) Regulation of liver regeneration. Nephrol Dial Transplant 19(Suppl 4):iv6-iv10
58. Fujiyoshi M, Ozaki M (2011) Molecular mechanisms of liver regeneration and protection for treatment of liver dysfunction and diseases. J Hepatobiliary Pancreat Sci 18:13-22
59. Leist M, Gantner F, Bohlinger I, Tiegs G, Germann PG, Wendel A (1995) Tumor necrosis factor-induced hepatocyte apoptosis precedes liver failure in experimental murine shock models. Am J Pathol 146:1220-1234
60. Tapalaga D, Tiegs G, Angermuller S (2002) Nfkappab and caspase-3 activity in apoptotic hepatocytes of galactosamine-sensitized mice treated with tnfalpha. J Histochem Cytochem 50:1599-1609 (Pubitemid 36078125)
61. Neuman MG (2001) Apoptosis in diseases of the liver. Crit Rev Clin Lab Sci 38:109-166
62. Bohlinger I, Leist M, Gantner F, Angermuller S, Tiegs G, Wendel A (1996) DNA fragmentation in mouse organs during endotoxic shock. Am J Pathol 149:1381-1393 (Pubitemid 26337255)
63. Morikawa A, Sugiyama T, Kato Y, Koide N, Jiang GZ, Takahashi K, Tamada Y, Yokochi T (1996) Apoptotic cell death in the response of D-galactosamine- sensitized mice to lipopolysaccharide as an experimental endotoxic shock model. Infect Immun 64:734-738 (Pubitemid 26065541)
64. Baskin-Bey ES, Washburn K, Feng S, Oltersdorf T, Shapiro D, Huyghe M, Burgart L, Garrity-Park M, van Vilsteren FG, Oliver LK, Rosen CB, Gores GJ (2007) Clinical trial of the pan-caspase inhibitor, idn-6556, in human liver preservation injury. Am J Transplant 7:218-225 (Pubitemid 44952876)
65. Eipel C, Hildebrandt A, Scholz B, Schyschka L, Minor T, Kreikemeyer B, Ibrahim SM, Vollmar B (2011) Mutation of mitochondrial atp8 gene improves hepatic energy status in a murine model of acute endotoxemic liver failure. Life Sci 88:343-349